Interdisciplinary E-health Based Follow-up of Preterm Born Children

NCT ID: NCT06345664

Last Updated: 2025-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess mental and somatic symptoms of preterm born children at the ages of 2, 5 and 10 by a multidisciplinary team and to evaluate an app that screens for these symptoms. Furthermore, there will be an evaluation of an intervention by our multidisciplinary team that provides recommendations for further treatment and diagnostic procedures of the children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* At first, there will be focus groups with experts and affected families to finalize and optimize the study procedure. After that, 90 children will be recruited (ages 2, 5 and 10)
* T0: App-questions for the children at the ages of 5 and 10 and the parents of all children to mental, somatic and sleep problems of the children and well-being of the parents, sleep tracking and recording of a sleep sequence of the children; differentiated examinations and questionnaires to mental and somatic problems of the children by interdisciplinary study team
* Interdisciplinary study team meeting to generate recommendations for the families
* Interdisciplinary study team recommendations for the families
* T1: Comparable to T0 but only measurements that were assessed with questionnaires/at home plus post-experimental questionnaire
* Focus groups with participating families and the study team experts for evaluation of the study procedure and intervention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diagnostic assessments and intervention

All families get a diagnostics and intervention recommendations.

Group Type OTHER

Diagnostics and intervention recommendations

Intervention Type OTHER

All families get the same diagnostics and receive individual treatment recommendations.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diagnostics and intervention recommendations

All families get the same diagnostics and receive individual treatment recommendations.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Differentiated diagnostics and treatment recommendations

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female and male preterm born children (\<32 week of pregnancy) that are treated at the clinic in Tübingen and their parents
* Existence of systematical neonatal data and consent of the care person to use this data
* Existence of the data of the 2 year regular follow-up (for the 5 and 10 year olds)

Exclusion Criteria

* lack of access to a mobile phone/tablet including internet access
* insufficient knowledge of the German language of both parents
Minimum Eligible Age

2 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Tuebingen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PD Dr. Annette Conzelmann

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Annette Conzelmann, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen

Axel Franz, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen

Mirja Quante, Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen

Ándrea Bevot, Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen

Tobias Renner, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tuebingen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Tuebingen

Tübingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Annette Conzelmann, Prof. Dr.

Role: CONTACT

004970712987513

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Annette Conzelmann, Prof. Dr.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

548/2022BO1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.